Caldwell Sutter Capital’s Sight Sciences SGHT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.8K Hold
2,000
﹤0.01% 601
2026
Q1
$7.54K Hold
2,000
﹤0.01% 591
2025
Q4
$15.9K Hold
2,000
0.01% 501
2025
Q3
$6.88K Hold
2,000
﹤0.01% 597
2025
Q2
$8.26K Hold
2,000
﹤0.01% 561
2025
Q1
$4.8K Hold
2,000
﹤0.01% 630
2024
Q4
$7.28K Sell
2,000
-250
-11% -$1.14K ﹤0.01% 592
2024
Q3
$14.2K Hold
2,250
0.01% 518
2024
Q2
$15K Buy
2,250
+250
+13% +$1.48K 0.01% 514
2024
Q1
$10.6K Hold
2,000
0.01% 541
2023
Q4
$10.3K Hold
2,000
0.01% 544
2023
Q3
$6.74K Buy
+2,000
New +$13.1K ﹤0.01% 565

Other funds holding SGHT

Caldwell Sutter Capital's SGHT Position: Q2 2026 in Review

Caldwell Sutter Capital held its Sight Sciences (SGHT) position steady in Q2 2026 at 2,000 shares worth $10.8K. The position accounts for ﹤0.01% of the portfolio, ranked #601.

Caldwell Sutter Capital first reported a position in SGHT in Q3 2023 and has held it in 12 quarters since. The position peaked at $15.9K in Q4 2025. 112 funds tracked by Wall St. Rank hold SGHT as of Q2 2026.

  • Caldwell Sutter Capital held 2,000 shares of Sight Sciences worth $10.8K as of Q2 2026.
  • Caldwell Sutter Capital left its Sight Sciences share count unchanged in Q2 2026.
  • Sight Sciences made up ﹤0.01% of Caldwell Sutter Capital's portfolio in Q2 2026, its #601 holding.
  • Caldwell Sutter Capital first reported a position in Sight Sciences in Q3 2023 and has held it in 12 quarters since.
  • Caldwell Sutter Capital's Sight Sciences position peaked at $15.9K in Q4 2025.
  • 112 funds tracked by Wall St. Rank held Sight Sciences as of Q2 2026.

Based on Caldwell Sutter Capital's 13F filing for Q2 2026, filed 5 Aug 2026.